DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Ando K, Ohtsu H, Uchida S. et al.
Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic
hypertensive patients with albuminuria: a double-blind, randomised,
placebo-controlled trial.
Lancet Diabetes Endocrinol 2014;
2: 944-953
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.